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BACKGROUND

NURSES’ HPV VACCINE ATTITUDES, BELIEFS AND PRACTICES

▪ Human papillomavirus (HPV) infection, with 13 million new infections every
year, is the most common sexually transmitted infection in the US
▪ In Montana, the HPV vaccine series completion remained at considerably
low rates of 60.3% and 48.8% among girls and boys respectively in 2020,
far below the Healthy People 2030 goal of 80%
▪ Nurses and medical assistants play a key role in adolescent immunization
services. Understanding their perceptions toward current barriers to HPV
vaccine is crucial in designing strategies to improve HPV vaccine uptake in
Montana
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▪ Our aim was to identify nurses’ attitudes, beliefs, perceptions, and
current practices regarding adolescent immunization.
▪ Our long-term goal is to optimize nurses’ impact in HPV vaccine
promotion in Montana.
METHODS
▪ A survey instrument was developed based on a review of existing
literature.
▪ We pilot tested the survey with a diverse group of 7 nurses using
cognitive interviewing techniques (Think-out aloud, Probing).
▪ In collaboration with DPHHS, electronic surveys were administered via
REDCap to a state-wide network of nurses and medical assistants
working at any public, private, or Tribal facility participating in the
Vaccines for Children (VFC) federal program.
▪ Surveys were administered from December 2020 to March 2021.
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“We see a fair amount of teen girls who have received the first
dose but do not return for the subsequent dose(s) because they
felt the vaccine was too painful or the parents do not bring them
back for doses that are not scheduled with routine yearly exams.”
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“The patient population we see comes in for confidential family
planning services and the Parental consent is a HUGE barrier to
providing this if they are not current for HPV vaccines”

SUPPORT OF STRATEGIES TO INCREASE VACCINE UPTAKE
Emphasizing cancer prevention when discussing the HPV
vaccine with parents and older children and adolescents
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Partnering with religious leaders to promote vaccinations in
general to their congregations
Assembling a quality team focused on increasing HPV
vaccination rates in our clinic

Proportion of respondents reporting over 50%
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“Lack of education for parents for long term efficacy of the
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Resistance
the vaccine protects these kids for the future. "If there were a
vaccine for breast cancer, would you get it? Then why not for
cervical or throat cancer?“
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Respondents identified the following as major barriers to HPV vaccination:
▪ Parental lack of knowledge that the vaccine is necessary for boys (76%)
▪ Misinformation from social media regarding the HPV vaccine (75%)
▪ Parental concerns about the safety of the HPV vaccine (69%)

PURPOSE
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▪ Training opportunities for effective communication strategies will help nurses
provide stronger and effective HPV vaccine recommendations.
▪ Engaging parents through school or community-based education campaigns,
counseling parents on vaccine safety and the importance of HPV vaccine for
boys, facilitating wide-spread adoption of reminder/recall systems, and partnering
with the state health department are some other strategies identified by nurses to
increase HPV vaccine uptake in Montana.
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